Takeda eyes $14.2 billion Nycomed deal: report

The other three are Credit Suisse's (CSGN.VX Last year, Nycomed bought a majority stake in a Chinese pharmaceutical company, underscoring its focus on emerging markets and Western manufacturers' hunger to boost their presence in the country. It paid...